Stock 000513 LIVZON PHARMACEUTICAL GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Company Livzon Pharmaceutical Group Inc.

Equities

000513

CNE0000002Y8

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 25/04/2024 BST 		5-day change 1st Jan Change
38.98 CNY -1.32% Intraday chart for Livzon Pharmaceutical Group Inc. +2.99% +11.34%
04-26 Livzon Pharmaceutical Factory Receives Approval for the U.S. FDA Approval for the Company's Drug Cetrorelix Acetate for Injection CI
04-24 Livzon Pharmaceutical's Q1 Profit Jumps 4.5%; Revenue Slips 5% MT

Business Summary

LIVZON PHARMACEUTICAL GROUP INC. is a China based company principally engaged in the research and development, production and sales of pharmaceutical products. The Company's main products include western medicine preparation such as gastrointestinal drugs, cardiovascular drugs and antimicrobial drugs and gonadotrophin drugs, Chinese medicine preparation, active pharmaceutical ingredient and intermediates, diagnostic reagents and equipments. The Company distributes its products in the domestic market and to overseas markets.

Number of employees: 8,933

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chemical Agents
52.9 %
7,000 55.4 % 6,571 52.9 % -6.13%
APIs and Intermediates
26.2 %
3,138 24.8 % 3,253 26.2 % +3.66%
Traditional Chinese Medicine
14.0 %
1,254 9.9 % 1,745 14.0 % +39.19%
Diagnostic Reagents and Equipment
5.3 %
724 5.7 % 659 5.3 % -8.92%
Biological
0.7 %
408 3.2 % 84 0.7 % -79.33%
Other Business
0.4 %
42 0.3 % 49 0.4 % +18.26%
Sales Materials, Processing Fees, Etc.
0.4 %
- - 46 0.4 % -
Others
0.1 %
- - 14 0.1 % -
Rental
0.1 %
7 0.1 % 9 0.1 % +29.96%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
87.3 %
10,959 87.5 % 10,754 87.3 % -1.86%
Overseas
12.7 %
1,565 12.5 % 1,571 12.7 % +0.40%

Managers

Managers TitleAgeSince
Yang Gang Tang PSD
 President 55 16/07/18
Yan Xia Si DFI
 Director of Finance/CFO 56 31/03/93
Maolin Wang CHM
 Chairman 59 31/12/00
Bao Guo Zhu CHM
 Chairman 62 31/12/01
Guo Xiang Xu BRD
 Director/Board Member 61 28/02/07
De Sheng Tao BRD
 Director/Board Member 60 31/12/84
De Long Ye IRC
 Investor Relations Contact - -
Yu Xuan Huang PRN
 Corporate Officer/Principal 57 24/10/18
Dai Hong Yang PRN
 Corporate Officer/Principal 58 31/12/96
Liang Yang SEC
 Corporate Secretary 41 31/07/11

Members of the board

Members of the board TitleAgeSince
Bao Guo Zhu CHM
 Chairman 62 31/12/01
Qiu Sheng Tian BRD
 Director/Board Member 68 14/10/19
Hua Min Huang BRD
 Director/Board Member 53 31/05/13
De Sheng Tao BRD
 Director/Board Member 60 31/12/84
Guo Xiang Xu BRD
 Director/Board Member 61 28/02/07
Xiong Yu BRD
 Director/Board Member 63 31/08/13
Hua Bai BRD
 Director/Board Member 55 29/06/20
Hui Yuan Luo BRD
 Director/Board Member 57 05/07/21
Yin Tang BRD
 Director/Board Member 49 28/12/15
Yang Gang Tang PSD
 President 55 16/07/18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 0 310,011,513 0 2,476,300 ( 0.7988 %) 38.32 %
Stock B 1 619,552,203 356,180,843 ( 57.49 %) 2,152,600 ( 0.3474 %)

Shareholders

NameEquities%Valuation
JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.
52.73 %
163,364,672 52.73 % 556 M ¥
UBS Asset Management (Hong Kong) Ltd.
2.417 %
7,487,622 2.417 % 25 M ¥
eQ Varainhoito Oy
0.5648 %
1,750,000 0.5648 % 6 M ¥
Bosera Asset Management Co., Ltd.
0.3899 %
1,207,900 0.3899 % 4 M ¥
Nordea Investment Management AB
0.1810 %
560,800 0.1810 % 2 M ¥
HSBC Jintrust Fund Management Co. Ltd.
0.1393 %
431,600 0.1393 % 1 M ¥
State Street Global Advisors Ltd.
0.1275 %
394,997 0.1275 % 1 M ¥
Robeco Hong Kong Ltd.
0.1062 %
328,900 0.1062 % 1 M ¥
RAM Active Investments SA
0.0514 %
159,154 0.0514 % 541 938 ¥
China Asset Management (Hong Kong) Ltd.
0.0471 %
145,979 0.0471 % 497 076 ¥
NameEquities%Valuation
JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.
42.20 %
255,513,953 42.20 % 1 290 M ¥
Penghua Fund Management Co., Ltd.
1.252 %
7,578,135 1.252 % 38 M ¥
GF Fund Management Co., Ltd.
1.222 %
7,401,479 1.222 % 37 M ¥
Huatai-PineBridge Fund Management Co., Ltd.
1.105 %
6,690,097 1.105 % 34 M ¥
LIVZON PHARMACEUTICAL GROUP INC.
0.9627 %
5,829,048 0.9627 % 29 M ¥
China Southern Asset Management Co., Ltd.
0.7555 %
4,574,325 0.7555 % 23 M ¥
Yinhua Fund Management Co., Ltd.
0.5330 %
3,226,992 0.5330 % 16 M ¥
China Asset Management Co., Ltd.
0.4878 %
2,953,231 0.4878 % 15 M ¥
China Fund Management Co., Ltd.
0.4804 %
2,908,700 0.4804 % 15 M ¥
Guotai Asset Management Co., Ltd.
0.4687 %
2,837,970 0.4687 % 14 M ¥

Holdings

NameEquities%Valuation
LIVZON PHARMACEUTICAL GROUP INC.
0.96%
 5,829,048 0.96% 29,437,800 $

Company contact information

Livzon Pharmaceutical Group, Inc.

Headquarters Building 38 Chuangye North Road

519090, Zhuhai

+86 75 6813 5888

http://www.livzon.com.cn
address Livzon Pharmaceutical Group Inc.(000513)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Sales per region

Ratings for Livzon Pharmaceutical Group Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
7
Last Close Price
38.98 CNY
Average target price
40.8 CNY
Spread / Average Target
+4.68%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
LIVZON PHARMACEUTICAL GROUP INC. Stock Livzon Pharmaceutical Group Inc.
+11.34% 4.34B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+25.83% 661B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+27.19% 566B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.76% 352B
MERCK & CO., INC. Stock Merck & Co., Inc.
+20.34% 332B
ABBVIE INC. Stock AbbVie Inc.
+3.00% 283B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.55% 231B
NOVARTIS AG Stock Novartis AG
+4.47% 200B
ROCHE HOLDING AG Stock Roche Holding AG
-9.45% 195B
AMGEN INC. Stock Amgen Inc.
-6.26% 145B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 000513 Stock
  4. Company Livzon Pharmaceutical Group Inc.